Serodus ASA (SER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Serodus ASA (SER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Serodus ASA (SER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Serodus ASA (SER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
30 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Serodus ASA (Serodus) is a drug development company that develops novel therapeutic products for the treatment of cardiovascular diseases and diabetes. The companys product pipeline includes SER100TRISH, SER150DN, SER100PH, SER130AMI and SER140T2D. Its products are used in the areas of diabetic nephropathy, type 2 diabetes, acute myocardial infarction, pulmonary hypertension, and isolated systolic hypertension. Seroduss pulmonary hypertension is a chronic, progressive disease characterized by elevated blood pressure in the pulmonary arteries. The company markets its products through distributors in the US, England, France, Germany, Spain, Italy and Japan.

Serodus ASA (SER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detaile

  
Source:
Document ID
GDPH228270D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Serodus ASA, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Serodus ASA, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Serodus ASA, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Serodus ASA, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Serodus ASA, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Serodus ASA, Pharmaceuticals &Healthcare, Deal Details1017
  Asset Purchase101
    Serodus Completes Acquisition Of ZP-120 From Zealand Pharma102
  Venture Financing121
    Serodus Raises US$0.09 Million In Venture Financing121
    Serodus Secures US$0.9 Million In New Round Of Financing131
  Licensing Agreements141
    Evolva And Serodus Enter Into Licensing Agreement For EV-077142
    Serodus Terminates Licensing Agreement With Roche For SER-101161
    Serodus Enters into Licensing Agreement with Zealand Pharma for SER100171
    Serodus Enters Into Licensing Agreement With F. Hoffmann-La Roche181
  Equity Offering191
    Serodus Raises USD1.2 Million in Private Placement of Shares191
    Serodus to Raise up to USD3.7 Million in Rights Offering of Shares201
    Serodus Completes Public Offering of Shares for USD1.71 Million211
    Serodus Completes Private Placement Of Shares For US$4.9 Million222
    Serodus Completes IPO Of US$0.7 Million242
  Acquisition261
    Serodus Completes Acquisition of Phlogo for USD0.9 Million261
Serodus ASA - Key Competitors271
Key Employees281
Locations And Subsidiaries291
  Head Office291
Appendix301
  Methodology301
  About GlobalData301
  Contact Us301
  Disclaimer301

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Serodus ASA (SER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Serodus-ASA-SER-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-18529>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Serodus ASA (SER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Serodus-ASA-SER-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-18529>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research